Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Candida albicans , the causative agent of mucosal infections, including oropharyngeal candidiasis (OPC), as well as bloodstream infections, is becoming increasingly resistant to existing treatment options. In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat off-label diseases is a promising strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Changes in the host-specific environment, including alterations in iron levels, can cause variations in the C. albicans burden and affect its virulence 2).”
From High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of Candida albicans in oropharyngeal candidiasis (2022) · cites this paper as [2]
In the citing paper
“C. albicans MP65, an iron-regulated surface mannoprotein [2] was shown to bind P. gingivalis cells.”
From High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of Candida albicans in oropharyngeal candidiasis (2022) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization of the oral fungal microbiome (mycobiome) in healthy individuals
Ghannoum, M. A., Jurevic, R. J., Mukherjee, P. K., Cui, F., Sikaroodi, M., Naqvi, A., & Gillevet, P. M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000713 · Cited by 1,150 · cited 1×
“The yeast Candida albicans is the most abundant member of the oral fungal community, or the mycobiome (1).”
BackgroundCandidalysin is a fungal peptide toxin critical for mucosal infection
Moyes, D. L., Wilson, D., Richardson, J. P., Mogavero, S., Tang, S. X., Wernecke, J., Höfs, S., Gratacap, R. L., Robbins, J., Runglall, M., et al. (2016) · Nature · doi:10.1038/nature17625 · Cited by 942 · cited 1×
“Adhesion assays were performed using a TR146 epithelial cell monolayer as described previously (41).”
MethodAntifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
Skrzypek, M. S., Binkley, J., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw924 · Cited by 455 · cited 1×
“Based on gene descriptions in the Candida Genome Database (CGD) (24), 25 genes (Table 1) out of the 106 DEGs either were regulated by transcriptional factors (Hap43, Sfu1, Sef1, and Tup1) involved in the regulation of iron metabolism (7, 25), were directly regulated by iron (ALS2 and PGA48) (8), or had iron-related fu…”
MethodRevisiting the source of candidemia: skin or gut?
Nucci, M., & Anaissie, E. (2001) · Clinical Infectious Diseases · doi:10.1086/323759 · Cited by 424
de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01351 · Cited by 350
A High-Affinity Iron Permease Essential for Candida albicans Virulence
Ramanan, N., & Wang, Y. (2000) · Science · doi:10.1126/science.288.5468.1062 · Cited by 336 · cited 1×
“albicans lacking a high-affinity iron permease transporter, FTR1, is avirulent in systemic infection (11).”
BackgroundAlmeida, R. S., Brunke, S., Albrecht, A., Thewes, S., Laue, M., Edwards, J. E., Filler, S. G., & Hube, B. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000217 · Cited by 330 · cited 2×
“upregulation of ALS3 were conducted either in mice without any chelator treatment (30) or ex vivo with OE cells (29), and it is important to note that a compensatory function within the ALS family has been proposed (31).”
BackgroundChen, C., Pande, K., French, S. D., Tuch, B. B., & Noble, S. M. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.07.005 · Cited by 314 · cited 6×
“albicans transcriptome (7, 8); the chromatome, or the state of the chromatin in terms of accessibility to the DNA replication machinery (9); and signals into Cek1 (9) and Hog1 (10) mitogen-activated protein kinase (MAPK) pathways to alter virulence traits, such as”
BackgroundMethodInfluentialThe iron chelator deferasirox protects mice from mucormycosis through iron starvation
Ibrahim, A. S., Gebermariam, T., Fu, Y., Lin, Husseiny, M. I., French, S. W., Schwartz, J., Skory, C. D., Edwards, J. E., & Spellberg, B. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32338 · Cited by 308 · cited 1×
“(21) as well as synergy with antifungals against Cryptococcus neoformans in vitro (22).”
Background
Cited by
Iron Metabolism and Immune Regulation
Ni, S., Yuan, Y., Kuang, Y., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.816282 · Cited by 259
“On the contrary, deferasirox, a Food and Drug Administration (FDA)-approved iron chelator, reduced neutrophil-mediated inflammation significantly (35), demonstrating that the depletion of iron in vivo reduces the amount and recruitment of neutrophils.”
BackgroundJin, X., Zhang, M., Lu, J., Duan, X., Chen, J., Liu, Y., Chang, W., & Lou, H. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.016 · Cited by 75
Kim, J. H., Cheng, L. W., Chan, K. L., Tam, C. C., Mahoney, N., Friedman, M., Shilman, M. M., & Land, K. M. (2020) · Antibiotics · doi:10.3390/antibiotics9110812 · Cited by 71
“albicans Preventive deferasirox treatment significantly reduced the fungal burden in tongue tissue [137]”
BackgroundDeferasirox (ExJade): An FDA-Approved AIEgen Platform with Unique Photophysical Properties
Sedgwick, A. C., Yan, K., Mangel, D. N., Shang, Y., Steinbrueck, A., Han, H., Brewster, J. T., Hu, X., Snelson, D. W., Lynch, V. M., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c11641 · Cited by 65
bu, X., & Wang, L. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5480 · Cited by 62
“Conversely, iron chelators such as deferasirox can significantly reduce neutrophil‑mediated inflammation, highlighting the potential therapeutic role of modulating iron levels to control excessive inflammatory responses (88).”
Tripathi, A., Liverani, E., Tsygankov, A. Y., & Puri, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013413 · Cited by 56
“In contrast, fungal cells in mice treated with the iron chelator deferasirox showed lower neutrophil recruitment in the tongue tissue during oropharyngeal candidiasis (52).”
BackgroundSelf-citationAdaptation to iron deficiency in human pathogenic fungi
Martínez-Pastor, M. T., & Puig, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118797 · Cited by 47
In vitroinfection models to study fungal–host interactions
Last, A., Maurer, M., Mosig, A. S., Gresnigt, M. S., & Hube, B. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab005 · Cited by 49
Iron Chelation in Local Infection
Scott, C., Arora, G., Dickson, K., & Lehmann, C. (2021) · Molecules · doi:10.3390/molecules26010189 · Cited by 43
“DFX reaches peak plasma concentration within one and a half to four hours after oral administration.”
BackgroundInfluentialTuning the Solid- and Solution-State Fluorescence of the Iron-Chelator Deferasirox
Hu, X., Sedgwick, A. C., Mangel, D. N., Shang, Y., Steinbrueck, A., Yan, K., Zhu, L., Snelson, D. W., Sen, S., Chau, C. V., et al. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c01155 · Cited by 39
Trace metal elements: a bridge between host and intestinal microorganisms
Ma, Y., Fei, Y., Ding, S., Jiang, H., Fang, J. Q., & Liu, G. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2359-4 · Cited by 39
“albicans to reduce the risk of pathogen infection (Puri et al., 2019).”
BackgroundRegulatory and pathogenic mechanisms in response to iron deficiency and excess in fungi
Pijuan, J., Moreno, D. F., Yahya, G., Moisa, M., Ul Haq, I., Krukiewicz, K., Mosbah, R., Metwally, K., & Cavalu, S. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14346 · Cited by 37
“This treatment has been tested in murine models of OC, which resulted in a significant reduction on C. albicans CFU per gram of tongue tissue, as well as reduced salivary iron levels and neutrophil-mediated inflammation (Puri et al., 2019).”
Sala, A., Ardizzoni, A., Spaggiari, L., Vaidya, N., van der Schaaf, J., Rizzato, C., Cermelli, C., Mogavero, S., Krüger, T., Himmel, M., et al. (2023) · mBio · doi:10.1128/mbio.00107-23 · Cited by 37
“albicans virulence in both oral and vaginal murine disease models, although this might be attributable to a direct antifungal effect as well (68, 69).”
BackgroundThe progress and future of the treatment of Candida albicans infections based on nanotechnology
Gao, Y., Cao, Q., Xiao, Y., Wu, Y., Ding, L., Huang, H., Li, Y., Yang, J., & Meng, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02841-6 · Cited by 34
“8E) [179].”
A double-edged sword with a therapeutic target: iron and ferroptosis in immune regulation
Ni, S., Yuan, Y., Song, S., & Li, X. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuac071 · Cited by 30
Pentland, D. R., Davis, J., Mühlschlegel, F. A., & Gourlay, C. W. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00238-z · Cited by 28
Pseudomonas Synergizes with Fluconazole against Candida during Treatment of Polymicrobial Infection
Hattab, S., Dagher, A.-M., & Wheeler, R. T. (2022) · Infection and Immunity · doi:10.1128/iai.00626-21 · Cited by 22
Alternative oxidase promotes high iron tolerance in Candida albicans
Sharma, R., Gibb, A., Barnts, K. L., Elrod, J. W., & Puri, S. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02157-23 · Cited by 20
“Total intracellular iron in C. albicans cells grown in varying iron concentrations was evaluated, as previously described (37).”
MethodSelf-citationCandida albicans Oropharyngeal Infection Is an Exception to Iron-Based Nutritional Immunity
Solis, N. V., Wakade, R. S., Filler, S. G., & Krysan, D. J. (2023) · mBio · doi:10.1128/mbio.00095-23 · Cited by 20
“albicans replication in 152 the oral cavity, an approach that has shown pre-clinical efficacy in mouse models (21).”
Hsu, L.-H., Kwaśniewska, D., Wang, S.-C., Shen, T., Wieczorek, D., & Chen, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-59750-5 · Cited by 19
Comprehensive Review on Candidemia: Epidemiology, Diagnosis, Treatment, and Future Directions
Dong, H., Song, M., Sun, J., Luan, X., Zhang, M., Wang, Y., Dong, Y., Sai, L., Li, Y., & Chang, W. (2026) · iFungi · doi:10.26599/ifungi.2026.9670005 · Cited by 18
Tripathi, A., Nahar, A., Sharma, R., Kanaskie, T., Al-Hebshi, N., & Puri, S. (2022) · Journal of Oral Microbiology · doi:10.1080/20002297.2022.2044110 · Cited by 16
“In line with the above results (Figure 1), reduced iron levels in mice with the iron chelator DFX, on the other hand, decreased the oral fungal burden during OPC [2].”
ResultSelf-citation“Nutrient–fungi–host” tripartite interaction in cancer progression
Wu, D., Guan, Y., Li, C., Zheng, Q., Yin, Z., Wang, H., & Liu, N. (2024) · iMeta · doi:10.1002/imt2.170 · Cited by 15
Neutrophil swarming is crucial for limiting oral mucosal infection by Candida albicans
Saraswat, D., Rojas, I. G., Kumar, R., Li, R. Q., Salvatori, O., Irimia, D., & Edgerton, M. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae239 · Cited by 15
“9 With progressive infection, C. albicans produces white tongue plaques consisting of an adherent biofilm that disrupts the tongue filiform papillae, whose hyphae penetrate into the corneum stratum (CS) and the epithelium.”
Self-citationSmall molecule based anti-virulence approaches against Candida albicans infections
Kalimuthu, S., Alshanta, O. A., Krishnamoorthy, A. L., Pudipeddi, A., Solomon, A. P., McLean, W., Leung, Y. Y., Ramage, G., & Neelakantan, P. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.2025337 · Cited by 14
“albicans in oral epithelial cells and significantly reduced fungal burdens in a murine model of oropharyngeal candidiasis (Puri et al. 2019).”
BackgroundImpact of the repurposed drug thonzonium bromide on host oral-gut microbiomes
Simón‐Soro, Á., Kim, D., Li, Y., Liu, Y., Ito, T., Sims, K. R., Benoit, D. S. W., Bittinger, K. L., & Koo, H. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-00181-5 · Cited by 14
Maurya, M. R., & Chauhan, A. (2023) · New Journal of Chemistry · doi:10.1039/d2nj05277f · Cited by 13
Pan, M., Wang, Q., Liu, Y., Xiao, N., Niu, X., Wu, D., Wang, T., Yan, G., & Shao, J. (2022) · Medical Mycology · doi:10.1093/mmy/myac011 · Cited by 11
Bortolami, M., Pandolfi, F., Messore, A., Rocco, D., Feroci, M., Santo, R. D., Vita, D. D., Costi, R., Cascarino, P., Simonetti, G., et al. (2021) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2021.128087 · Cited by 11
Mechanisms and regulation of iron uptake and the role of iron in pathogenesis of Candida albicans
Zheng, D., Zhang, X., Ding, J., Yue, D., Yang, F., & Li, Y. (2025) · Critical reviews in microbiology · doi:10.1080/1040841x.2025.2510256 · Cited by 10
“Similarly, treatment with deferasirox reduced fungal burden and inflammation in a model of oral candidiasis (Puri et al. 2019). beyond general nutritional immunity, the host can establish iron-restricted zones at infection sites, imposing additional iron deficiency stress on the pathogen (Potrykus…”
Homeostatic control of an iron repressor in a GI tract resident
Wang, Y., Mao, Y., Chen, X., Huang, X., Jiang, Z., Yang, K., Tian, L., Jiang, T., Zou, Y., Ma, X., et al. (2023) · eLife · doi:10.7554/elife.86075 · Cited by 10
Chai, X., Jiang, Y., Lu, H. J., & Huang, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574990 · Cited by 9
Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
Chrayteh, D., Vaulont, S., & Peyssonnaux, C. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.09.020 · Cited by 9
Liao, B., Zhang, C., Shen, J., Chen, D., Wang, J., Chen, X., Zhou, Y., Wei, Y., Shi, Y., Gou, L., et al. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13411-7 · Cited by 7
“…approved by the US Food and Drug Administration (FDA), do not affect the hyphal morphology of C. albicans but significantly reduce its survival rate within neutrophils, ultimately leading to a significant reduction in fungal burden in murine models of oropharyngeal candidiasis (Puri et al. 2019).”
Mechanisms and Therapeutic Potential of Nutritional Immunity
Ugwu, C. E., Akinsulie, O. C., Ayandokun, T. F., Ajibade, F. A., Shahzad, S., Aliyu, V. A., Oladoye, M. J., Idris, I., Obasi, K. O., Edeh, J. K., et al. (2026) · Pathogens · doi:10.3390/pathogens15020176 · Cited by 7
Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy
Puumala, E., Nabeela, S., Thornburg, C. C., Grkovic, T., Uppuluri, P., Whitesell, L. J., O’Keefe, B. R., Robbins, N., & Cowen, L. E. (2024) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01194-24 · Cited by 4
“Thus, the chelation of zinc by naamidine A presents a potential antifungal strategy in settings where exogenous metal availability is limited, such as the topical treatment of fungal skin and nail infections (7, 10–12).”
Erfaninejad, M., Aboualigalehdari, E., & Fatahinia, M. (2023) · Jundishapur Journal of Microbiology · doi:10.5812/jjm-132692 · Cited by 4
Deletion of RAP1 affects iron homeostasis, azole resistance, and virulence in Candida albicans
Yang, M.-C., Huang, W.-L., Chen, H., Lin, S.-H., Chang, Y.-S., Tseng, K., Lo, H., Wang, I., Lin, C.-J., & Lan, C. (2025) · mSphere · doi:10.1128/msphere.00155-25 · Cited by 3
“The iron chelator deferasirox can reduce C. albicans invasion of oral epithelial cells and infection in murine oropharyngeal candidiasis (21).”
Giuso, V., Thierry, T., Gourlaouen, C., Mercandelli, P., Vanthuyne, N., Mauro, M., & Bellemin‐Laponnaz, S. (2025) · Dalton Transactions · doi:10.1039/d5dt00392j · Cited by 2
Shinohara, T., Wada, A., Abe, M., Oiki, S., Koizumi, A., Otani, A., Katano, H., & Miyazaki, Y. (2025) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00856-25 · Cited by 2
“…deferiprone and deferasirox, originally developed for the treatment of iron overload in patients requiring chronic blood transfusions, have demonstrated encouraging results in both murine (29–31) and human (32–34) models of fungal infections, including candidiasis, mucormycosis, and aspergillosis.”
Romina, A., Larypoor, M., & Bayat, M. (2025) · Archives of Razi Institute · doi:10.66224/ari.2025.367485.3399 · Cited by 2
Deferasirox (ExJade): A Fluorescent Pro-Chelator Active Against Antibiotic Resistant BacteriaPreprint
Sedgwick, A. C., Yan, K., Mangel, D. N., Shang, Y., Steinbrueck, A., Han, H., Brewster, J. T., Hu, X., Snelson, D. W., Lynch, V. M., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12040518.v1 · Cited by 2
Deferasirox (ExJade): A Fluorescent Pro-Chelator Active Against Antibiotic Resistant BacteriaPreprint
Sedgwick, A. C., Yan, K., Mangel, D. N., Shang, Y., Steinbrueck, A., Han, H., Brewster, J. T., Hu, X., Snelson, D. W., Lynch, V. M., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12040518 · Cited by 2
The Fight for Iron: A Central Theme in Host-Pathogen Interactions
Hamad, M. A. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_11 · Cited by 1
Deferasirox Targets TAOK1 to Induce p53-Mediated Apoptosis in Esophageal Squamous Cell Carcinoma
Li, B., Liu, S., Zhou, X., Hou, D., Jia, H., Tang, R., Zhang, Y., & Song, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041524 · Cited by 1
Feng, X., Gan, X., Ren, B., Wan, Z., Wang, Y., Gao, X., & Zhu, Z. (2025) · Journal of Oral Microbiology · doi:10.1080/20002297.2025.2589655 · Cited by 1
“Additionally, this transport system has potential for Candida infections through siderophore production [57].”
Hsu, L.-H., Chou, Y. Y., Shen, T., Wieczorek, D., & Chen, Y. (2025) · Virulence · doi:10.1080/21505594.2025.2609407 · Cited by 1
“Iron sequestering thus plays an important role in humans to prevent C. albicans from invading, which is called nutritional immunity [12,13].”
Research progress on iron metabolism in the occurrence and development of periodontitis
Yang, Y., Wei, Y., & Chen, L. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0037
Infection Models for Human Pathogenic Fungi
Jacobsen, I. D. (2024) · The mycota · doi:10.1007/978-3-031-64853-3_9
Metadata
- Authors
- Puri, S., Kumar, R., Rojas, I. G., Salvatori, O., & Edgerton, M.
- Affiliations
- Temple University (US)
- University at Buffalo, State University of New York (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2019-04
- Volume
- 63
- Issue
- 4
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC6437492
- OpenAlex
- W2914721725
- Cited by
- 48
- References
- 44
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 7 · 2023: 8 · 2022: 7 · 2021: 7 · 2020: 8
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- HHS | NIH | National Institute of Dental and Craniofacial Research (R01DE022720, R01DE010641, R03DE026451)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Dentistry › General Dentistry › HIV/AIDS oral health manifestations
- Health Sciences › Dentistry › General Dentistry › Oral Health Pathology and Treatment
- Keywords
- deferasirox, iron chelators, Candida albicans, oropharyngeal candidiasis, oral epithelial cells, fungal invasion, drug repurposing, antifungal therapy, mouse model
- MeSH terms
- Deferasirox, Animals, Antifungal Agents, Candida albicans, Candidiasis, Oral, Cell Adhesion, Cells, Cultured, Epithelial Cells, Female, Humans, Iron, Iron Chelating Agents, Mice, Inbred C57BL, Mouth Mucosa, Neutrophils, Saliva, Tongue, Gene Expression Regulation, Fungal, Oxidative Stress, Mice, Drug Repositioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.